// App-Quantinova.ai

802 : Improvement in the Clinical Global Impression of Change with Voxelotor in Patients with Sickle Cell Disease in the Phase 3 HOPE Trial

Researchers

Presenter

  • Wally R Smith

Principal Investigators

  • Jane S. Hankins

  • Miguel R Abboud

  • Ze Cong

  • Jonathan Sorof

  • Sarah Gray

  • Carolyn Hoppe

  • Paul Telfer

Medical Centers

  • Virginia Commonwealth University, Mineral, VA

  • Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN

  • Global Blood Therapeutics, South San Francisco, CA

  • Barts Health NHS Trust, London, United Kingdom

Locations

  • United States

  • Lebanon

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Sickle cell anemia

Biomarkers

  • Stearoyl-CoA desaturase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Controlled

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved